Akebia Therapeutics, Inc.

NASDAQ:AKBA

Biotechnology

Healthcare
$0.41 +0.49%

+$0.01 today

Market cap
$113.54M
Beta
0.25
P/E (TTM)
-13.3
EPS (TTM)
-$0.08
52W Low $0.82High $4.08

Volume 7.09M

Average 4.03M

Price history

Akebia Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-74.28%

Period high

$1.70

Period low

$0.40

Latest

$0.41

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
8-KOct 23, 2026Oct 23, 2026
8-KOct 14, 2026Oct 14, 2026
4Aug 10, 2026Aug 10, 2026
10-QAug 5, 2026Aug 5, 2026
S-8Aug 5, 2026Aug 5, 2026
8-KAug 5, 2026Aug 5, 2026
4Jul 1, 2026Jul 1, 2026
8-KJun 30, 2026Jun 30, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026
8-KJun 22, 2026Jun 22, 2026
4Jun 22, 2026Jun 22, 2026

Competitors

Who does Akebia Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about AKBA's filings, answered from its disclosures.

What is the latest AKBA filing?

The latest filing shown is 8-K dated Nov 5, 2026.

How many recent filings does AKBA have?

Intrinsic Alpha currently shows 20 recent filings for AKBA.